These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 17998832

  • 1. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F, Rashidi M, Hashemi S, Kangavari M, Bahari A, Daryani NE, Emam MM, Naderi N, Shalmani HM, Farnood A, Zali M.
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [Abstract] [Full Text] [Related]

  • 2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M.
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [Abstract] [Full Text] [Related]

  • 3. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
    Ben Hamida KS, Serghini M, Ksontini I, Kedadi H, Ben Yaghléne L, Bougassas W, Dougui MH.
    Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
    [Abstract] [Full Text] [Related]

  • 4. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C, Steder-Neukamm U, Glas K, Sander S, Ring C, Klaus J, Reinshagen M.
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P.
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [Abstract] [Full Text] [Related]

  • 6. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA, Hamdy NA.
    Scand J Gastroenterol Suppl; 2006 Dec; (243):59-64. PubMed ID: 16782623
    [Abstract] [Full Text] [Related]

  • 7. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F.
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [Abstract] [Full Text] [Related]

  • 8. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN, Leslie WD.
    Aliment Pharmacol Ther; 2004 May 01; 19(9):941-52. PubMed ID: 15113361
    [Abstract] [Full Text] [Related]

  • 9. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
    Kluge G, Borte M, Richter T, Kahn T, Borte G.
    Rofo; 2007 Jan 01; 179(1):58-64. PubMed ID: 17203445
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC, Huijberts MS, Schoon EJ, Geusens P, de Vries J, Menheere PP, van der Veer E, Wolffenbuttel BH, Stockbrugger RW, Dumitrescu B, Nieuwenhuijzen Kruseman AC.
    Eur J Gastroenterol Hepatol; 2008 Aug 01; 20(8):740-7. PubMed ID: 18617778
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B, Li P, Lv H, Li Y, Wang O, Xing XP, Qian JM.
    J Dig Dis; 2014 Mar 01; 15(3):116-23. PubMed ID: 24354597
    [Abstract] [Full Text] [Related]

  • 12. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A.
    Gastroenterol Clin Biol; 2003 Oct 01; 27(10):901-7. PubMed ID: 14631305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
    Henderson S, Hoffman N, Prince R.
    Am J Gastroenterol; 2006 Jan 01; 101(1):119-23. PubMed ID: 16405543
    [Abstract] [Full Text] [Related]

  • 15. [Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease].
    Scheer K, Kratzsch J, Deutscher J, Gelbrich G, Borte G, Kiess W.
    Klin Padiatr; 2004 Jan 01; 216(2):62-6. PubMed ID: 15106075
    [Abstract] [Full Text] [Related]

  • 16. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.
    Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A.
    Eur J Gastroenterol Hepatol; 1995 Jul 01; 7(7):609-14. PubMed ID: 8590154
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.
    Dumitrescu G, Mihai C, Dranga M, Prelipcean CC.
    Rev Med Chir Soc Med Nat Iasi; 2013 Jul 01; 117(1):23-8. PubMed ID: 24505888
    [Abstract] [Full Text] [Related]

  • 18. Altered bone metabolism in inflammatory bowel disease.
    Bischoff SC, Herrmann A, Göke M, Manns MP, von zur Mühlen A, Brabant G.
    Am J Gastroenterol; 1997 Jul 01; 92(7):1157-63. PubMed ID: 9219790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Low bone mineral density in children with Crohn's disease].
    Bourges O, Dorgeret S, Alberti C, Hugot JP, Sebag G, Cézard JP.
    Arch Pediatr; 2004 Jul 01; 11(7):800-6. PubMed ID: 15234375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.